BioNTech, Duality score initial trial win with breast cancer precision drug – Reuters

Written by

admin

in

  1. BioNTech, Duality score initial trial win with breast cancer precision drug  Reuters
  2. BioNTech Surges 10% As Cancer Smart Bomb Succeeds  Investor’s Business Daily
  3. Study success for DualityBio’s ADC boosts BioNTech’s oncology ambitions  FirstWord Pharma
  4. BioNTech and Duality Biologics Announce BNT323 Reached Main Goal in Clinical Trials  Pharmaceutical Executive
  5. BioNTech Says Experimental Breast Cancer Drug Succeeded in Trial  Bloomberg.com

Continue Reading

More posts